Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
CJC-1295 is a GHRH analog stimulating growth hormone release. Key FAQs address dosing (100-300 mcg weekly with DAC), side effects (water retention, carpal tunnel symptoms), stacking (Ipamorelin synergy), safety (favorable at research doses), and legal status (research chemical, banned in sports). Most users see results within 2-4 weeks, with significant body composition changes after 8-12 weeks of consistent use.
Why Do Users Combine CJC-1295 with Ipamorelin?
CJC-1295 and Ipamorelin work synergistically through different endocrine pathways. CJC-1295 stimulates GHRH receptors on somatotroph cells, while Ipamorelin stimulates ghrelin receptors through a separate mechanism. When combined, both pathways converge on the same cells, creating larger and more frequent growth hormone pulses than either peptide alone.
This stack amplifies GH secretion significantly—a widely supported approach in research and among experienced practitioners. The CJC + Ipamorelin combination is considered the gold-standard GH-secretagogue stack for achieving superior results with manageable complexity and cost.
How Long Does It Take to See Results from CJC-1295?
Sleep quality and recovery improvements typically appear within 1-2 weeks of the first injection. Users report falling asleep faster, experiencing deeper sleep, and waking more refreshed. Body composition changes—increased lean mass and decreased body fat—become visible around 4-8 weeks when combined with proper nutrition and progressive resistance training.
Full realization of the anabolic and metabolic effects generally requires 12+ weeks of consistent use. Strength improvements typically emerge around week 4-6, becoming substantial by week 8. Continued gains depend on training quality, dietary adherence, sleep, and cycling strategy.
Does CJC-1295 Suppress Natural Testosterone Production?
No, CJC-1295 does not directly suppress testosterone production like exogenous anabolic steroids do. The peptide works exclusively through the GHRH pathway and does not interfere with the hypothalamic-pituitary-gonadal (HPG) axis, which governs testosterone synthesis and secretion.
At standard research doses (100-300 mcg), indirect hormone interactions are minimal and clinically insignificant. Men can maintain full testosterone function and libido while using CJC-1295. This is a major advantage over testosterone replacement therapy or anabolic steroids, which suppress natural production.
Can Women Safely Use CJC-1295?
Yes, women can safely use CJC-1295 with generally identical dosing protocols to men (100-300 mcg weekly with DAC). The peptide has no androgenic properties and does not suppress estrogen production or alter menstrual cycles. Some research suggests women may be more sensitive to GH elevation, potentially benefiting from the lower end of dosing ranges.
The peptide does not cause virilization (facial hair, voice deepening, clitoral enlargement) or disrupt hormonal function in women. Female users report similar body composition benefits as men, with additional benefits for skin quality, bone density, and recovery.
What Is the Difference Between CJC-1295 with DAC and Without DAC?
CJC-1295 with DAC (Drug Affinity Complex) has a half-life of approximately 8 days, allowing once-weekly injection. Without DAC, the half-life is approximately 30 minutes, requiring 2-3 daily injections for sustained GH elevation. Both versions stimulate GH through the same GHRH receptor mechanism but differ fundamentally in pharmacokinetics and practical use.
DAC provides steady, sustained GH elevation with convenient weekly injection; no-DAC creates acute GH spikes with each injection, more closely mimicking natural pulsatile GH secretion but requiring daily injections. Most users prefer DAC for convenience; some prefer no-DAC for a more physiological GH pattern despite injection inconvenience.
Is CJC-1295 Legal to Purchase and Use?
CJC-1295 is classified as a research chemical and is not FDA-approved for human use. It is legal to purchase for research purposes in most countries, though legality varies by jurisdiction. Reputable online vendors sell CJC-1295 openly under the "for research use only" classification.
It is banned by WADA (World Anti-Doping Agency) in competitive sports. Always verify local regulations before purchasing—some jurisdictions may have restrictions on research peptides. Using CJC-1295 makes you ineligible to compete in tested sports.
What Are the Realistic Results from CJC-1295 Use?
Most users report improved recovery, better sleep quality, and modest but significant body composition improvements. Realistic expectations for an 8-12 week cycle include 5-10 lbs lean muscle gain and 5-15 lbs fat loss, particularly when combined with progressive resistance training and caloric management.
Results are significantly enhanced when CJC-1295 is combined with Ipamorelin (10-20% better outcomes). The more disciplined the training and nutrition, the more dramatic the results. Beginners and those with good genetics see more pronounced gains than advanced lifters or those with limiting genetics.
Can I Use CJC-1295 Year-Round?
Most practitioners recommend standard cycling protocols: 8-12 weeks on, 4 weeks off, rather than continuous year-round use. This cycling approach maintains receptor sensitivity to GHRH stimulation and prevents tachyphylaxis (receptor desensitization) that can diminish response over time with continuous use.
The "off" period (4 weeks) allows the natural GH axis time to reset and recover. Many experienced users employ variations like 10 weeks on / 4 weeks off or 12 weeks on / 6 weeks off. The principle remains: cycling preserves long-term efficacy better than continuous use.
What Should I Do If I Experience Side Effects?
Most CJC-1295 side effects are dose-dependent and fully reversible. If experiencing water retention, reducing dose by 50-100 mcg often resolves the issue within 1-2 weeks. Staying well-hydrated and managing sodium intake (under 2,300 mg daily) helps mitigate water retention.
For carpal tunnel-like symptoms (hand tingling/numbness), wrist bracing, dose reduction, and avoiding repetitive hand movements help manage symptoms. If side effects persist after dose reduction, discontinuing use allows rapid resolution. Most users experience only mild, manageable side effects at conservative dosing.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →Frequently Asked Questions
Q: What is CJC-1295?
CJC-1295 (Modified GRF 1-29) is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog—a peptide hormone that stimulates the anterior pituitary gland to secrete natural growth hormone. It contains the first 29 amino acids of natural GHRH plus four amino acid substitutions for enhanced stability.
Q: How often should CJC-1295 be injected?
CJC-1295 with DAC: typically once weekly via subcutaneous injection (100-300 mcg). CJC-1295 without DAC: 2-3 times daily due to its 30-minute half-life. Most users prefer the DAC version for convenience and consistent GH elevation.
Q: What are the most common side effects?
Dose-dependent water retention (facial and abdominal puffiness) and carpal tunnel-like symptoms (hand tingling, numbness) are the most common. Increased appetite, mild headaches, and injection-site flushing occasionally occur. All side effects are fully reversible with dose reduction or discontinuation.
Q: Is CJC-1295 FDA-approved for human use?
No, CJC-1295 is not FDA-approved for human treatment. It is classified as a research chemical and sold "for research purposes only." No US physician can legally prescribe CJC-1295 for medical use. However, it can be purchased legally for research in most jurisdictions.
Q: How does CJC-1295 affect testosterone?
CJC-1295 does not suppress testosterone. It works through the GHRH pathway and does not interfere with the hypothalamic-pituitary-gonadal axis that governs testosterone production. Users maintain normal testosterone levels and function while using CJC-1295.
Q: How long does it take to see noticeable results?
Sleep quality improvements typically appear within 1-2 weeks. Recovery and energy improvements follow within 2-4 weeks. Visible body composition changes (muscle gain, fat loss) typically emerge around week 4-8 with proper training and nutrition. Full results require 8-12 weeks of consistent use.